Back to News
Market Impact: 0.32

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

EOLS
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech

Evolus reported a quarterly loss of $0.10 per share, outperforming the Zacks Consensus Estimate for a $0.14 loss by $0.04 per share. The result also improved from a loss of $0.18 per share a year ago, indicating year-over-year earnings progress despite remaining unprofitable.

Analysis

Evolus reported a quarterly loss of $0.10 per share, outperforming the Zacks Consensus Estimate for a $0.14 loss by $0.04 per share. The result also improved from a loss of $0.18 per share a year ago, indicating year-over-year earnings progress despite remaining unprofitable.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.28

Ticker Sentiment

EOLS0.35